Tag Archives: Second Circuit summarily reverses bad Prevagen decision on statistical proof consumer protection

Second Circuit summarily reverses bad Prevagen decision on statistical proof

FTC v. Quincy Bioscience Holding Co., 17-3745-cv(L) (2d. Cir. Feb. 21, 2019) Quincy sold Prevagen dietary supplements, claiming (1) that the supplements improve memory and provide other cognitive benefits, (2) that these effects are clinically proven, and (3) that the … Continue reading

Posted in Uncategorized | Tagged , , | Leave a comment